ArticlePharmacoEconomics2017

An Early Health Economic Analysis of the Potential Cost Effectiveness of an Adherence Intervention to Improve Outcomes for Patients with Cystic Fibrosis.

Paul Tappenden et al.PubMed ↗Publisher ↗

No numbers read from the abstract.